Nanomedicine: Photo-activated nanostructured titanium dioxide, as a promising anticancer agent

Nefeli Lagopati1, Konstantinos Evangelou2, Polycarpos Falaras3

  • 1Laboratory of Histology-Embryology, Molecular Carcinogenesis Group, Faculty of Medicine, School of Health Science, National and Kapodistrian University of Athens, 75, Mikras Asias Str., Goudi, GR 11527 Athens, Greece; Laboratory of General Chemistry, School of Chemical Engineering, National Technical University of Athens, Zografou Campus, 9, Iroon Polytechniou str., GR 15780 Zografou, Athens, Greece.

Pharmacology & Therapeutics
|December 28, 2020
PubMed

Insights

Titanium dioxide (TiO2) nanoparticles show promise as an anticancer photosensitizer. When photo-excited, these nanoparticles generate reactive oxygen species (ROS) that damage cancer cells, offering a novel nanomedicine approach.

Area of Science:

  • Nanomedicine
  • Biomaterials Science
  • Oncology

Background:

  • Cancer treatment faces challenges with conventional methods, necessitating novel therapeutic strategies.
  • Nanomedicine offers potential solutions by leveraging advanced nanostructured materials.
  • Titanium dioxide (TiO2) nanoparticles possess biocompatibility and diverse applications, including biomedical uses.

Purpose of the Study:

  • To review the application of nanomedicine in cancer treatment.
  • To explore the anticancer effects mediated by titanium dioxide nanoparticles (TiO2-NPs).
  • To highlight nanotechnology achievements and TiO2-NPs as potential anticancer photosensitizers.

Main Methods:

  • Review of existing literature on nanomedicine and TiO2 nanoparticles in cancer research.
  • Analysis of the mechanism of TiO2 nanoparticle-mediated generation of reactive oxygen species (ROS).
  • Evaluation of TiO2-NPs as photosensitizers for cancer therapy.

Main Results:

  • Photo-excited TiO2 nanoparticles generate electron-hole pairs.
  • These pairs react with water and oxygen to produce ROS.
  • ROS have demonstrated efficacy in damaging cancer cells and triggering controlled cellular processes.

Conclusions:

  • TiO2 nanoparticles exhibit promising anticancer properties through ROS generation.
  • Nanotechnology, specifically TiO2-NPs, offers a potential advancement in cancer treatment.
  • TiO2-NPs are proposed as effective anticancer photosensitizers for future therapeutic development.